Results 51 to 60 of about 5,378 (170)
Postoperative tonsil/adenoidectomy bleeding management in patients with diagnosed bleeding disorders
Objective Tonsil/adenoidectomy (T/A) is a commonly performed procedure with an average post‐tonsillectomy bleed (PTB) rate between 3 and 5%. Patients with bleeding disorders (BDs) are believed to have an increased risk of PTB.
Kavya Pai +3 more
doaj +1 more source
The role of antifibrinolytic agents in gynecologic cancer surgery
OBJECTIVE: To compare the effects of crystalloid and colloid solutions, tranexamic acid and epsilon-aminocaproic acid on the need for allogenic blood transfusion and on coagulation and fibrinolysis parameters. METHODS: We conducted the study in the Anesthesiology and Reanimation Department of Hacettepe University Medical Faculty, Ankara, Turkey between
Nalan, Celebi +5 more
openaire +2 more sources
Abstract Purpose To evaluate the association between tranexamic acid (TXA) use, autologous predonation and perioperative blood management outcomes after periacetabular osteotomy (PAO) using an arm‐based multilevel meta‐analytic framework. Methods A systematic search of PubMed, Embase, Epistemonikos and the Cochrane Central Register of Controlled Trials
Nikolai Ramadanov +5 more
wiley +1 more source
Abstract Purpose To establish pooled benchmark estimates for perioperative blood loss and transfusion burden after periacetabular osteotomy (PAO) and to explore potential study‐level moderators across the available literature. Methods A systematic search of PubMed, Embase, Epistemonikos and CENTRAL was performed up to 30 March 2026.
Nikolai Ramadanov +5 more
wiley +1 more source
Background: During orthotopic liver transplantation (OLT), activation of the fibrinolytic system can contribute significantly to perioperative bleeding.
Devi A +4 more
doaj
Background Tranexamic acid (TXA) is widely used in orthopedic surgery to reduce perioperative bleeding. Since TXA inhibits fibrinolysis, there is concern that it may increase the risk of thromboembolic events. Objectives To verify the prevalence of deep
Ari Zekcer +4 more
doaj +1 more source
INTRODUÇÃO: O ácido épsilon aminocapróico é um antifibrinolítico usado em cirurgia cardiovascular a fim de inibir a fibrinólise e reduzir o sangramento após circulação extracorpórea (CEC).
Ricardo Adala Benfatti +5 more
doaj +1 more source
Perioperative Outcomes in Factor XI Deficiency: A Systematic Review
ABSTRACT Background Congenital factor XI (FXI) deficiency has a variable bleeding phenotype, and FXI activity alone does not predict perioperative bleeding. Management practices remain heterogeneous, and available evidence derives from case reports, small case series, and retrospective cohorts.
Zainab Al‐Housni +6 more
wiley +1 more source
A novel biosensor for measuring plasmin activity
Background: Plasmin facilitates fibrinolysis by catalyzing the degradation of fibrin clots. Reliable methods to assess fibrinolysis by measuring plasmin generation are needed in the preclinical and clinical settings.
Ying Dai +4 more
doaj +1 more source
OBJETIVO: Verificar o efeito do uso tópico do ácido epsilon-aminocapróico (AEAC), aplicado na cavidade pericárdica, na redução do sangramento e necessidade de transfusão sanguínea no pós-operatório de revascularização cirúrgica do miocárdio.
João Roberto Breda +7 more
doaj +1 more source

